Skip to main content

Clarus Therapeutics Holdings, Inc.

CRXTDelisted Sep 14, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001817944

Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.

Superinvestors holding CRXT, Q2 2022

See all superinvestors

No superinvestor reported holding CRXT in Q2 2022.